Trabikibart is a fully human betac-specific monoclonal antibody, designated CSL311, that binds with picomolar affinity to the cytokine-binding epitope of the human betac receptor. Trabikibart exhibits potent inhibitory activity against the collective biological effects of IL-3, GM-CSF, and IL-5 on eosinophil survival, positioning it as a promising biologic agent for the study of chronic inflammatory and eosinophil-associated disorders.
Purity:
99.30%
CAS Number:
[2643974-98-3]
Target:
c-Fms|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
